MA26856A1 - Bisindolymaleimides substitues pour l'inhibition de la proliferation de cellules - Google Patents

Bisindolymaleimides substitues pour l'inhibition de la proliferation de cellules

Info

Publication number
MA26856A1
MA26856A1 MA26691A MA26691A MA26856A1 MA 26856 A1 MA26856 A1 MA 26856A1 MA 26691 A MA26691 A MA 26691A MA 26691 A MA26691 A MA 26691A MA 26856 A1 MA26856 A1 MA 26856A1
Authority
MA
Morocco
Prior art keywords
bisindolymaleimides
inhibition
substituted
cell proliferation
proliferation
Prior art date
Application number
MA26691A
Other languages
English (en)
Inventor
Nader Fotouhi
Emily Aijun Liu
John Guilfoyle Mullin Jr
Guiseppe Federico Weber
Allen John Lovey
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA26856A1 publication Critical patent/MA26856A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • C07F9/5728Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MA26691A 1999-12-16 2002-06-14 Bisindolymaleimides substitues pour l'inhibition de la proliferation de cellules MA26856A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17105199P 1999-12-16 1999-12-16

Publications (1)

Publication Number Publication Date
MA26856A1 true MA26856A1 (fr) 2004-12-20

Family

ID=22622296

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26691A MA26856A1 (fr) 1999-12-16 2002-06-14 Bisindolymaleimides substitues pour l'inhibition de la proliferation de cellules

Country Status (33)

Country Link
US (1) US6313143B1 (fr)
EP (1) EP1242408B1 (fr)
JP (2) JP2003516986A (fr)
KR (1) KR100507422B1 (fr)
CN (1) CN1229374C (fr)
AR (1) AR029415A1 (fr)
AT (1) ATE306484T1 (fr)
AU (1) AU783616B2 (fr)
BR (1) BRPI0016329B8 (fr)
CA (1) CA2392902C (fr)
CO (1) CO5050293A1 (fr)
CZ (1) CZ304130B6 (fr)
DE (1) DE60023182T2 (fr)
ES (1) ES2249314T3 (fr)
GC (1) GC0000265A (fr)
HK (1) HK1054385B (fr)
HR (1) HRP20020513B1 (fr)
HU (1) HU230003B1 (fr)
IL (2) IL150128A0 (fr)
JO (1) JO2296B1 (fr)
MA (1) MA26856A1 (fr)
MX (1) MXPA02005560A (fr)
MY (1) MY126998A (fr)
NO (1) NO322240B1 (fr)
NZ (1) NZ519173A (fr)
PE (1) PE20011034A1 (fr)
PL (1) PL200243B1 (fr)
RS (1) RS50449B (fr)
RU (1) RU2264398C2 (fr)
TW (1) TWI274752B (fr)
UY (1) UY26485A1 (fr)
WO (1) WO2001044234A1 (fr)
ZA (1) ZA200204258B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102373A1 (fr) * 2001-06-15 2002-12-27 F. Hoffmann-La Roche Ag Procede d'administration d'un agent destine a la therapie du cancer
WO2003037384A2 (fr) * 2001-10-29 2003-05-08 Nektar Therapeutics Al, Corporation Conjugues polymeres d'inhibiteurs de proteine kinease c
JP6106437B2 (ja) * 2010-01-07 2017-03-29 アルカーメス ファーマ アイルランド リミテッド 複素芳香族化合物のプロドラッグ
EP2474541A1 (fr) * 2010-12-23 2012-07-11 Johannes- Gutenberg-Universität Mainz Composés conjugués de 3-(indolyl)- et 3-(azaindolyl)-4-arylmaléimide et leur utilisation dans le traitement de tumeurs

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK75289A3 (en) * 1988-02-10 1998-05-06 Hoffmann La Roche Substituted pyrroles, their use for producing a drug, and the drug on their base
MC2096A1 (fr) * 1989-02-23 1991-02-15 Hoffmann La Roche Pyrroles substitues
GB9416467D0 (en) * 1994-08-13 1994-10-05 Wellcome Found Compounds for use in medicine
US5977163A (en) * 1996-03-12 1999-11-02 Pg-Txl Company, L. P. Water soluble paclitaxel prodrugs
TW517067B (en) * 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
PE91698A1 (es) 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91498A1 (es) * 1996-07-29 1998-12-22 Hoffmann La Roche Pirroles sustituidos
PE91598A1 (es) 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
EP1045689A4 (fr) * 1998-01-09 2003-04-23 Univ Arizona State Synthese de phenstatine et promedicaments de celle-ci
WO1999047518A1 (fr) * 1998-03-17 1999-09-23 F. Hoffmann-La Roche Ag Bisindolymaleimides substitues destines a l'inhibition de la proliferation cellulaire
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
RU2002110111A (ru) * 1999-10-12 2003-12-20 Ф.Хоффманн-Ля Рош Аг (Ch) Замещенные пирролы в качестве антипролиферативных средств для лечения рака

Also Published As

Publication number Publication date
HK1054385B (zh) 2006-02-17
AR029415A1 (es) 2003-06-25
AU783616B2 (en) 2005-11-17
RS50449B (sr) 2010-03-02
GC0000265A (en) 2006-11-01
HU230003B1 (en) 2015-04-28
HUP0203696A3 (en) 2004-01-28
CN1229374C (zh) 2005-11-30
NZ519173A (en) 2004-06-25
DE60023182D1 (de) 2006-02-23
KR100507422B1 (ko) 2005-08-10
RU2002119209A (ru) 2004-01-10
CN1409709A (zh) 2003-04-09
MY126998A (en) 2006-11-30
BRPI0016329B8 (pt) 2021-05-25
ATE306484T1 (de) 2005-10-15
MXPA02005560A (es) 2002-09-02
US6313143B1 (en) 2001-11-06
JP2003516986A (ja) 2003-05-20
TWI274752B (en) 2007-03-01
KR20020063215A (ko) 2002-08-01
CA2392902C (fr) 2009-01-13
HUP0203696A2 (hu) 2003-03-28
NO322240B1 (no) 2006-09-04
DE60023182T2 (de) 2006-07-06
WO2001044234A1 (fr) 2001-06-21
BR0016329A (pt) 2002-08-27
BR0016329B1 (pt) 2013-03-19
AU2008201A (en) 2001-06-25
NO20022776L (no) 2002-06-11
HK1054385A1 (en) 2003-11-28
CZ20022447A3 (cs) 2003-06-18
EP1242408A1 (fr) 2002-09-25
JO2296B1 (en) 2005-09-12
NO20022776D0 (no) 2002-06-11
IL150128A0 (en) 2002-12-01
JP4763623B2 (ja) 2011-08-31
HRP20020513B1 (en) 2006-10-31
IL150128A (en) 2006-06-11
CA2392902A1 (fr) 2001-06-21
CZ304130B6 (cs) 2013-11-13
ZA200204258B (en) 2003-08-28
UY26485A1 (es) 2001-06-29
PL355856A1 (en) 2004-05-31
EP1242408B1 (fr) 2005-10-12
JP2007153905A (ja) 2007-06-21
CO5050293A1 (es) 2001-06-27
HRP20020513A2 (en) 2004-08-31
PE20011034A1 (es) 2001-10-12
RU2264398C2 (ru) 2005-11-20
PL200243B1 (pl) 2008-12-31
YU43302A (sh) 2005-03-15
ES2249314T3 (es) 2006-04-01

Similar Documents

Publication Publication Date Title
MA26914A1 (fr) Derives bicycliques substitues pour le traitement d'une croissance cellulaire anormale
DE69932032D1 (de) Inhibitoren der alpha4 vermittelten zelladhäsion
ID29021A (id) Komposisi galantamina pelepasan terkontrol
EP1092755A4 (fr) Composition pour revetement
NO20010899D0 (no) Forbedring av ugunstige apomorfin-effekter
PL342964A1 (en) Substituted bisindolymaleimides for the inhibition of cell proliferation
EP1225377A4 (fr) Bague d'etancheite
FR2781364B1 (fr) Cotyle pour prothese de hanche
BR9708106A (pt) Composição clarificante de água
FI990937A0 (fi) Tilaajahallinta
EP1214928A4 (fr) Stimulants pour la pousse de cheveux
NO20013146L (no) Middel for behandling av synscellefunksjonsforstyrrelse
FR2746016B1 (fr) Combinaisons d'enzymes pour la destruction de cellules proliferatives
MA26856A1 (fr) Bisindolymaleimides substitues pour l'inhibition de la proliferation de cellules
FR2797350B1 (fr) Plaque d'electrode pour accumulateur
EP1181353A4 (fr) Lignees cellulaires inductibles d'empaquetage pour la production de vecteurs lentiviraux
FR2751637B1 (fr) Cellule d'electrocoagulation pour le traitement d'effluents
ATE243218T1 (de) 2''-deoxyhygromycinderivate
MA24078A1 (fr) Procede pour l'utilisation de derives de tetrahydroisoquinoleine
PT1020132E (pt) Aba de puxar destacavel
FR2797869B1 (fr) Composition pour moulage
FR2801508B1 (fr) Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrhee
FR2759588B1 (fr) Compositions pour diminuer la sensibilite de la peau
EP1175834A4 (fr) Procede d'utilisation de composition bactericide
FR2798378B1 (fr) Composition pour moulage